Hemab Therapeutics Holdings, Inc. (COAG) Insider Trading

Sector: Biotechnology · Market Cap: $1.4B · 0 insider purchases in the last 7 days

No open market insider purchases at Hemab Therapeutics Holdings, Inc. in the last 7 days.

Want more?

Sign up free to see 30+ days of history, set alerts, and track COAG on your watchlist.

Start for Free

About Hemab Therapeutics Holdings, Inc. Insider Trading

1 insider at Hemab Therapeutics Holdings, Inc. (COAG) has purchased stock in the past 90 days, totaling $53.8M across 14 transactions (2,902,872 shares).

The most recent purchase was by 10%+ Owner RA CAPITAL MANAGEMENT, L.P. on May 20, 2026 — a $25K buy of 996 shares at $24.94, bringing their total holdings to 6,376,968 shares.

This insider buying is notable given that COAG had no recorded open market purchases in the nine months before that.

COAG is in the Biotechnology sector within the Biotechnology industry with a market cap of $1.4B.

Track COAG insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.

More Insider Trading in Biotechnology

Related Screeners